NCT03018223 · OUTCOME

Progression Free Survival (PFS)

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT · Source last updated 2021-09-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: percentage of participants
Interval / dispersion: 95% Confidence Interval
Time frame: Up to 1 year post HCT

What was measured

Progression-free survival defined by the time interval from transplant to relapse/recurrence, to death or to last follow-up. Reported as percentage of participants who are disease free one year post HCT.

Groups in this outcome

Conditioning/HCT/GVHD Prophylaxis

Pre-HCT Conditioning, HCT, GVHD Prophylaxis.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Conditioning/HCT/GVHD Prophylaxis	32

Reported measurements

Source class 1

Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
Group	Value	Spread	Lower	Upper	Comment
Conditioning/HCT/GVHD Prophylaxis	56.6	Not reported	41.3	77.7	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
lower Limit
41.3
upper Limit
77.7
value
56.6

denoms

counts
group Id
OG000
value
32
units
Participants

description

dispersion Type

95% Confidence Interval

groups

description
Pre-HCT Conditioning, HCT, GVHD Prophylaxis.
id
OG000
title
Conditioning/HCT/GVHD Prophylaxis

param Type

NUMBER

reporting Status

POSTED

time Frame

Up to 1 year post HCT

title

Progression Free Survival (PFS)

type

SECONDARY

unit Of Measure

percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice